Search
Search Results
##search.searchResults.foundPlural##
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3341PDF: 1417HTML: 4160 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1988PDF: 1228HTML: 343 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4443PDF: 1451HTML: 2202 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4201PDF: 1320HTML: 2122Table 1: 232 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3594PDF: 1454HTML: 2729 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1117PDF: 1074Suppl. Files: 674HTML: 197 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2370PDF: 625HTML: 375 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4970PDF: 1879HTML: 2872Untitled: 277 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1576PDF: 964Suppl. Files: 485HTML: 301 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8356PDF: 4496HTML: 7579 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2181PDF: 885HTML: 263 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2400PDF: 1117HTML: 2030Characteristic of study group: 237 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3447PDF: 1032HTML: 3177flowcytometric result of peripheral blood sample: 231 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1471PDF: 744HTML: 1393cover letter: 248 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4421PDF: 1595HTML: 478 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2087PDF: 809HTML: 728Table1: patient's characteristics: 203Table 2: profile of each patient: 220 -
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3396PDF: 1778HTML: 1172 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1966PDF: 878HTML: 10363Figures 1,2,3: 249 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2346PDF: 1051HTML: 4988 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1557PDF: 907HTML: 1117Untitled: 217 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1797PDF: 850HTML: 913jdoe, table 2 infections CML .doc: 247jdoe, table 1 infections CML .doc: 227 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
236PDF: 727HTML: 70 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3588PDF: 2342HTML: 23566Untitled: 265Untitled: 263Untitled: 281 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2367PDF: 879HTML: 1705Figure 1: 246Table 1: 252 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4186PDF: 2042HTML: 281 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3501PDF: 1575HTML: 4086







